Explanipedia

Neoadjuvant nivolumab and relatlimab in locally advanced MMR-deficient colon cancer: a phase 2 trial Open

P.G.M. de Gooyer, Y.L. Verschoor, L.D.W. van den Dungen, Sara Balduzzi, Hendrik A. Marsman , et al. · 2024

Adjuvant Hyperthermic Intraperitoneal Chemotherapy in Patients With Locally Advanced Colon Cancer (COLOPEC): 5-Year Results of a Randomized Multicenter Trial Open

Emma S. Zwanenburg, Charlotte E.L. Klaver, D D Wisselink, Cornelis J.A. Punt, Pétur Snæbjörnsson , et al. · 2023

Clinical trials frequently include multiple end points that mature at different times. The initial report, typically based on the primary end point, may be published when key planned co-primary or secondary analyses are not yet available. …

Adhesion formation after surgery for locally advanced colonic cancer in the COLOPEC trial Open

Emma S. Zwanenburg, D D Wisselink, Charlotte E.L. Klaver, Alexandra Brandt, André J. A. Bremers , et al. · 2022

This study investigated the impact of laparoscopic or open resection of locally advanced colonic cancer on the incidence and severity of adhesions evaluated by laparoscopy at 18 months, primarily intended to evaluate peritoneal recurrence.…

Adjuvant hyperthermic intraperitoneal chemotherapy in patients with locally advanced colon cancer (COLOPEC): a multicentre, open-label, randomised trial Open

Charlotte E.L. Klaver, D D Wisselink, Cornelis J.A. Punt, Pétur Snæbjörnsson, Johannes Crezee , et al. · 2019

Factors influencing long‐term survival after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for pseudomyxoma peritonei originating from appendiceal neoplasms Open

W J van Eden, Niels F.M. Kok, Pétur Snæbjörnsson, Katarzyna Jóźwiak, Karlijn Woensdregt , et al. · 2019

CEA and CA19-9 levels raised more than threefold above the upper limit identify patients with PMP of appendiceal origin and poorer survival.

Karlijn Woensdregt YOU? Author Swipe